UpRight Science Brings Together Expert Advisory Board to Advance Balance as an Essential Health Measure

Multidisciplinary group brings expertise across medicine, neuroscience, healthcare technology, business, and communications to support the company's mission to make balance easier to measure and track.

WEST PALM BEACH, Fla., Sept. 16, 2026 /PRNewswire/ -- With Falls Prevention Awareness Week approaching Sept. 21–25, UpRight Science today announced the advisory board supporting its work to establish balance as an essential measure of health and expand the usage of its FDA-cleared balance software.

The announcement comes as the national spotlight turns toward one of the most serious threats to healthy aging. Falls are the leading cause of injury among Americans ages 65 and older, with more than 14 million older adults, or roughly one in four, reporting a fall each year. UpRight Science believes better visibility into balance can help make this critical aspect of health easier to understand, measure, and track over time.

"Advisory boards are often assembled around credentials. What is rare here is the degree of personal conviction behind those credentials," said Terry Chabrowe, CEO of UpRight Science. "Every member of this group understands how profoundly mobility and balance can affect a person's health and independence, and our mission to improve and extend lives resonates deeply with each of them. That shared passion, combined with an extraordinary range of expertise, will be invaluable as we work to change the way balance is understood and measured."

The UpRight Science Advisory Board includes:

• Joseph Shurman, MD, Advisory Board Chair. Dr. Shurman is a board-certified anesthesiologist and pain medicine physician whose career has spanned clinical practice, medical leadership, research, and education. He is a former Chair of the Department of Anesthesiology and former Chair of Pain Management at Scripps Memorial Hospital, and briefly served as Co-Chair of Palliative Care. He also served as Medical Director of Clinical Research for the Anesthesia Medical Service Group (270 physicians), which covered all major hospitals in San Diego, and was formerly Chair of the pain management group. His major focus is risk management, particularly through his nationally recognized "Share the Risk" model, which was featured in a front-cover article and became recognized nationally at Scripps. The model was supported by the DEA, and Dr. Shurman also lectured on the model at a Department of Justice CME meeting.
  
  
• Frederick "Ted" Carrick, DC, PhD, MS-HPEd. Dr. Carrick is Professor of Neurology at the University of Central Florida College of Medicine, Adjunct Professor at the MGH Institute of Health Professions and Professor of Neurology, and Senior Research Fellow at the Centre for Mental Health Research in association with the University of Cambridge. His research and clinical work have encompassed vestibular rehabilitation, movement disorders, traumatic brain injury, concussion, and other neurological conditions, bringing important expertise in the complex systems that enable balance and human movement.
  
  
• Crystal Gurin. Gurin is a media, marketing, and digital business executive with more than three decades of experience building companies and new market categories. A longtime publisher of eMarketer and co-founder of pioneering digital advertising company Cybereps, she brings UpRight extensive experience translating emerging technologies and ideas into concepts that businesses and consumers can understand and adopt.
  
  
• Angela Murray, RN, BScN, MN. Murray is a healthcare executive and strategic advisor with more than 30 years of experience spanning healthcare strategy, market access, and health economics. During her tenure with Baxter and Hillrom, she led the global Market Access and Health Economics and Outcomes Research function, helping translate clinical and economic evidence into strategies supporting reimbursement, funding, and adoption of healthcare technologies across global markets. She brings UpRight a systems-level perspective on what it takes to move a promising health innovation from clinical value to meaningful adoption and impact.
  
  
• Isaac Treitel. Treitel is the co-founder and Managing Partner of MedPro Investors and director of TriState Ventures, with more than 20 years of experience investing in and advising early-stage life science and technology companies. His work evaluating emerging technologies and helping young companies navigate financial and operational growth gives UpRight an experienced perspective on building and scaling a new category of health technology.

"Balance is a simple concept, but there is nothing simple about the work required to establish it as an essential biomarker," said Sanjeev Sharma, MD, Chief Medical Officer of UpRight Science. "It takes rigorous science and the ability to translate a new measurement into something clinicians and patients can meaningfully use. That is why the diversity of voices and experience represented on this advisory board is so important. They will help us strengthen the evidence and move balance toward the place we believe it belongs in routine health assessment."

UpRight Science is advancing BALANCE: THE SIXTH VITAL SIGN™, based on the idea that balance can provide meaningful information about health and function but historically has lacked an easy, objective way to be measured outside specialized settings. The company's FDA-cleared software uses the sensors already built into smartphones to reliably measure balance and identify changes over time, extending the ability to assess balance beyond the clinic or doctor's office.

UpRight Science has also developed StayUpRight!, a free consumer app that gives anyone a simple way to check and track their balance using a smartphone. Together, the company's medical and consumer technologies are designed to make objective balance measurement more accessible and help bring greater attention to a dimension of health that has long been difficult to quantify.

About UpRight Science

UpRight Science is a medical technology company advancing BALANCE: THE SIXTH VITAL SIGN™. The FDA-cleared balance software from UpRight Science turns any smartphone into a medical device (SaMD). The company uses smartphone-based biomechanics to reliably measure balance, identify changes in balance over time, and extend patient care beyond the clinic or doctor's office.

Its free consumer app, StayUpRight!, brings a non-prescription version of the same technology to everyday users, offering a first look at what objective balance tracking makes possible. StayUpRight! is provided for general wellness purposes and is not a medical device. App users who are concerned about their balance should consult with their physician.

Contact:

Lori Luechtefeld
WIT Strategy
[email protected]

SOURCE UpRight Science